ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,661Medicare Part D Prescriptions Filled, Including Refills

Rank: 469 out of 3647

$758K Total Retail Price of All Prescriptions

Rank: 469 out of 3647

814 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 11,978 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 1,128 970 1 2
OMEPRAZOLE 785 623 2 3
LOVASTATIN 639 570 3 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 603 491 4 36
METFORMIN HCL 552 475 5 6
FUROSEMIDE 368 315 6 8
CARVEDILOL 355 313 7 20
LISINOPRIL 349 284 8 4
VIAGRA 345 278 9 69
NAPROXEN 315 257 10 70
LOSARTAN POTASSIUM 267 232 11 11
SIMVASTATIN 260 199 12 1
METOPROLOL TARTRATE 253 215 13 7
LOSARTAN-HYDROCHLOROTHIAZIDE 221 202 14 48
IBUPROFEN 202 148 15 55
TAMSULOSIN HCL 198 173 16 28
LANTUS 182 141 17 59
HYDROCHLOROTHIAZIDE 182 159 17 9
LUMIGAN 149 148 19 291
INSULIN SYRINGE 149 115 19 76
PLAVIX 143 130 21 39
GLYBURIDE-METFORMIN HCL 139 120 R 22 94
TRAMADOL HCL 137 107 23 22
CLOPIDOGREL 136 125 24 26
CRESTOR 128 95 25 19
GABAPENTIN 127 93 26 17
FLUTICASONE PROPIONATE 127 104 26 32
POTASSIUM CHLORIDE 123 102 28 24
GLIMEPIRIDE 123 109 28 45
MECLIZINE HCL 122 122 30 85
WARFARIN SODIUM 119 94 31 15
ATORVASTATIN CALCIUM 118 83 32 13
ADVAIR DISKUS 115 57 33 52
NORTRIPTYLINE HCL 113 93 34 273
MELOXICAM 109 96 35 33
CLOTRIMAZOLE-BETAMETHASONE 109 86 35 84
ATENOLOL 104 93 37 10
SPIRIVA 94 48 38 93
DONEPEZIL HCL 91 91 39 30
NOVOLIN 70-30 89 70 40 130
PROAIR HFA 86 76 41 62
ALLOPURINOL 85 83 42 37
DOXAZOSIN MESYLATE 84 65 43 57
NIFEDIPINE ER 78 63 44 67
RANITIDINE HCL 74 71 45 29
TIZANIDINE HCL 73 57 46 126
HYDRALAZINE HCL 73 64 46 81
SINGULAIR 71 24 48 90
LATANOPROST 68 68 49 218
LEVOTHYROXINE SODIUM 67 64 50 5
NAMENDA 67 52 50 49
ALENDRONATE SODIUM 66 57 52 23
NIFEDIAC CC 65 57 53 325
METOPROLOL SUCCINATE 62 44 54 18
FINASTERIDE 62 62 54 66
PRAVASTATIN SODIUM 61 50 56 16
FLUOXETINE HCL 61 53 56 68
COMBIVENT 60 34 58 170
SYMBICORT 58 49 59 153
HUMALOG 57 45 60 239
COMBIGAN 53 52 61 401
SPIRONOLACTONE 53 24 61 77
DIGOXIN 52 45 63 51
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 64 74
TRAVATAN Z 51 44 64 293
ISOSORBIDE MONONITRATE ER 51 51 64 56
LEVETIRACETAM 50 41 67 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.